BIOMAT Database Logo BIOMAT Database Logo

Comparative binding of p53 to its promoter and DNA recognition elements. 2005

Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Cambridge University Chemical Laboratory and MRC Centre for Protein Engineering, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH, UK.

Tumor suppressor p53 is a transcription factor that transactivates a wide range of genes, including those in DNA repair, cell cycle arrest, apoptosis and its own degradation. To estimate the role of selectivity in binding to its promoters, we measured the binding affinities of a tetrameric p53 construct (p53CT) in vitro with 20 of its recognition elements from a variety of representative genes. The binding of full length p53 to four representative sequences exactly paralleled the affinities to p53CT. The binding of p53 to different recognition elements was co-operative and the affinities varied by up to 50-fold. p53 bound with high affinity to the recognition elements of all the genes involved in cell cycle arrest and some of the genes in apoptosis. All of the lower affinity-binding sites were in genes involved in apoptosis. Our quantitative-binding data were in agreement with published cell-based assays. The regulation of p53 activity is in part determined through the specificity of its DNA-binding interactions.

UI MeSH Term Description Entries
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D020218 Response Elements Nucleotide sequences, usually upstream, which are recognized by specific regulatory transcription factors, thereby causing gene response to various regulatory agents. These elements may be found in both promoter and enhancer regions. Element, Response,Elements, Response,Response Element

Related Publications

Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Symphony of the DNA flexibility and sequence environment orchestrates p53 binding to its responsive elements.
November 2021, Gene,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling.
May 2009, Nucleic acids research,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Influence of magnesium ion on the binding of p53 DNA-binding domain to DNA-response elements.
July 2009, Journal of biochemistry,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).
October 2006, The Journal of biological chemistry,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions.
August 1996, Journal of cellular biochemistry,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
May 2004, Oncogene,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.
September 1995, Proceedings of the National Academy of Sciences of the United States of America,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Diverse p53/DNA binding modes expand the repertoire of p53 response elements.
October 2017, Proceedings of the National Academy of Sciences of the United States of America,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Binding of p53 and its core domain to supercoiled DNA.
February 2001, European journal of biochemistry,
Richard L Weinberg, and Dmitry B Veprintsev, and Mark Bycroft, and Alan R Fersht
Protein-binding elements in the promoter region of the mouse p53 gene.
September 1990, Oncogene,
Copied contents to your clipboard!